COSCIENS Biopharma Inc 6-K, filed Mar 26, 2020
COSCIENS Biopharma Inc. (CSCIF)
About this 6-K
COSCIENS Biopharma Inc filed this 6-K on March 26, 2020.
UNITEDSTATES
SECURITIESAND EXCHANGE COMMISSION
Washington,D.C. 20549
FORM6-K
REPORTOF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
Forthe month of March 2020
Commission File Number: 001-38064
AeternaZentaris Inc.
(Translation of registrant’s name into English)
315Sigma Drive, Summerville, South Carolina, USA 29486
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): [ ]
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes [ ] No [X]
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
Exhibits
| Exhibit No. | Description |
|---|---|
| 99.1 | Amended Notice of Meeting and Record Date |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: March 26, 2020 | |
|---|---|
| AETERNA ZENTARIS INC. | |
| /s/ Leslie Auld | |
| Leslie Auld | |
| Senior Vice President and Chief Financial Officer |
Exhibit99.1
| March<br> 25, 2020 | <br> <br><br>1500<br> Robert-Bourassa Blvd., 7th Floor<br><br> <br>Montreal<br> QC, H3A 3S8<br><br> <br>www.computershare.com |
|---|---|
| To:<br> All Canadian Securities Regulatory Authorities | |
| Subject: Aeterna Zentaris Inc. | Amended |
| Dear Sir/Madam:<br><br><br><br><br><br><br><br>We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: | |
| Meeting<br> Type : | Annual<br> Meeting |
| Record<br> Date for Notice of Meeting : | April<br> 01, 2020 |
| Record<br> Date for Voting (if applicable) : | April<br> 01, 2020 |
| Beneficial<br> Ownership Determination Date : | April<br> 01, 2020 |
| Meeting<br> Date : | May 15, 2020 |
| Meeting<br> Location (if available) : | Virtual Meeting |
| Issuer<br> sending proxy related materials directly to NOBO: | No |
| Issuer<br> paying for delivery to OBO: | Yes |
| Notice and Access (NAA) Requirements: | |
| NAA<br> for Beneficial Holders | No |
| NAA<br> for Registered Holders | No |
| Voting Security Details: | |
| Description | CUSIP Number ISIN |
| COMMON<br> SHARES | 007975402 CA0079754028 |
Sincerely,
Computershare
Agent for Aeterna Zentaris Inc.